摘要 |
<p>Antibodies against TRAIL-R1 and TRAIL-R2 having at least one characteristic selected from among the following (a) to (c) or functional fragments thereof: (a) having an activity of inducing apoptosis of cancer cells expressing TRAIL-R1 and/or TRAIL-R2; (b) exerting no effect on normal human cells expressing TRAIL-R1 and/or TRAIL-R2; and (c) inducing no injury on human hapatocytes.</p> |